Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

The treatment of progressive non-Hodgkin's lymphoma with intensive chemoradiotherapy and autologous marrow transplantation.

Phillips GL, Fay JW, Herzig RH, Lazarus HM, Wolff SN, Lin HS, Shina DC, Glasgow GP, Griffith RC, Lamb CW, et al.

Blood. 1990 Feb 15;75(4):831-8.

2.

Treatment of progressive Hodgkin's disease with intensive chemoradiotherapy and autologous bone marrow transplantation.

Phillips GL, Wolff SN, Herzig RH, Lazarus HM, Fay JW, Lin HS, Shina DC, Glasgow GP, Griffith RC, Lamb CW, et al.

Blood. 1989 Jun;73(8):2086-92.

3.

Autologous bone marrow transplantation in non-Hodgkin's lymphoma: monoclonal antibodies plus complement for ex vivo marrow treatment.

Hurd DD, LeBien TW, Lasky LC, Haake RJ, Ramsay NK, Kim TH, Levine EG, McGlave PB, Bloomfield CD, Peterson BA, et al.

Am J Med. 1988 Dec;85(6):829-34.

PMID:
3057901
4.

Clinical outcome following autologous and allogeneic blood and marrow transplantation for relapsed diffuse large-cell non-Hodgkin's lymphoma.

Aksentijevich I, Jones RJ, Ambinder RF, Garrett-Mayer E, Flinn IW.

Biol Blood Marrow Transplant. 2006 Sep;12(9):965-72.

5.

Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.

Hagemeister FB.

Cancer Chemother Pharmacol. 2002 May;49 Suppl 1:S13-20. Epub 2002 Apr 12. Review.

PMID:
12042984
6.

Autologous bone marrow transplantation in B-cell non-Hodgkin's lymphoma: very low treatment-related mortality in 100 patients in sensitive relapse.

Freedman AS, Takvorian T, Anderson KC, Mauch P, Rabinowe SN, Blake K, Yeap B, Soiffer R, Coral F, Heflin L, et al.

J Clin Oncol. 1990 May;8(5):784-91.

PMID:
2332768
7.

Purging of bone marrow in autologous bone marrow transplantation for non-Hodgkin's lymphoma: a case-matched comparison with unpurged cases by the European Blood and Marrow Transplant Lymphoma Registry.

Williams CD, Goldstone AH, Pearce RM, Philip T, Hartmann O, Colombat P, Santini G, Foulard L, Gorin NC.

J Clin Oncol. 1996 Sep;14(9):2454-64.

PMID:
8823323
8.

Autologous bone marrow transplantation for non-transformed low-grade non-Hodgkin's lymphoma.

Cervantes F, Shu XO, McGlave PB, Ramsay NK, Miller WJ, Kersey JH, Weisdorf DJ.

Bone Marrow Transplant. 1995 Sep;16(3):387-92.

PMID:
8535311
9.

Syngeneic hematopoietic stem-cell transplantation for non-Hodgkin's lymphoma: a comparison with allogeneic and autologous transplantation--The Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation.

Bierman PJ, Sweetenham JW, Loberiza FR Jr, Taghipour G, Lazarus HM, Rizzo JD, Schmitz N, van Besien K, Vose JM, Horowitz M, Goldstone A; Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation.

J Clin Oncol. 2003 Oct 15;21(20):3744-53. Epub 2003 Sep 8.

PMID:
12963703
10.

Refractory or relapsed Hodgkin's disease and non-Hodgkin's lymphoma: optimizing involved-field radiotherapy in transplant patients.

Kahn ST, Flowers CR, Lechowicz MJ, Hollenbach K, Johnstone PA.

Cancer J. 2005 Sep-Oct;11(5):425-31.

PMID:
16259874
11.

[High dose chemoradiotherapy with autologous hemotopoietic stem cell transplantation for treatment of patients with advanced Hodgkin's lymphoma: a report of 11 cases].

Zhou SY, Shi YK, He XH, Han XH, Liu P, Yang JL, Zhou AP, Feng FY.

Ai Zheng. 2002 Apr;21(4):405-8. Chinese.

PMID:
12452021
12.

Rituximab for aggressive non-Hodgkin's lymphomas relapsing after or refractory to autologous stem cell transplantation.

Pan D, Moskowitz CH, Zelenetz AD, Straus D, Kewalaramani T, Noy A, Qin J, Teruya-Feldstein J, Portlock CS.

Cancer J. 2002 Sep-Oct;8(5):371-6.

PMID:
12416894
13.

The role of intensive therapy and autologous blood and marrow transplantation for chemotherapy-sensitive relapsed and primary refractory non-Hodgkin's lymphoma: identification of major prognostic groups.

Prince HM, Imrie K, Crump M, Stewart AK, Girouard C, Colwill R, Brandwein J, Tsang RW, Scott JG, Sutton DM, Pantalony D, Carstairs K, Sutcliffe SB, Keating A.

Br J Haematol. 1996 Mar;92(4):880-9.

PMID:
8616081
14.

Outcome of high-dose therapy and autologous transplantation in non-Hodgkin's lymphoma based on the presence of tumor in the marrow or infused hematopoietic harvest.

Sharp JG, Kessinger A, Mann S, Crouse DA, Armitage JO, Bierman P, Weisenburger DD.

J Clin Oncol. 1996 Jan;14(1):214-9.

PMID:
8558200
15.

Autotransplants for histologically transformed follicular non-Hodgkin's lymphoma.

Chen CI, Crump M, Tsang R, Stewart AK, Keating A.

Br J Haematol. 2001 Apr;113(1):202-8.

PMID:
11328303
16.
17.

Autologous bone marrow transplantation in adults with non-Hodgkin's lymphoma: a Southwest Oncology Group study.

Saez R, Dahlberg S, Appelbaum FR, Hartsock RJ, Lemaistre F, Coltman CA Jr, Fisher RI.

Hematol Oncol. 1994 Mar-Apr;12(2):75-85.

PMID:
8070756
19.

Allogeneic bone marrow transplantation for Hodgkin's and non-Hodgkin's lymphoma.

Mendoza E, Territo M, Schiller G, Lill M, Kunkel L, Wolin M.

Bone Marrow Transplant. 1995 Feb;15(2):299-303.

PMID:
7773222
20.

Autologous bone marrow transplantation for progressive non-Hodgkin's lymphoma: clinical impact of immunophenotype and in vitro purging.

Weisdorf DJ, Haake R, Miller WJ, McGlave PB, LeBien TW, Vallera DA, Lasky LC, Kim TH, Peterson BA, Ramsay NK, et al.

Bone Marrow Transplant. 1991 Aug;8(2):135-42.

PMID:
1933055
Items per page

Supplemental Content

Write to the Help Desk